Mahindra Manulife Mid Cap Fund - Direct Plan -Growth

Mahindra Manulife Mid Cap Fund - Direct Plan -Growth ranks among the stronger performers in the Mid Cap category, backed by a 4-star rating. Consistent 3-year performance combined with a strong rating makes this one of the more credible options in its space. TopFund's composite Health Score, which weighs rating, 3-year CAGR, expense ratio and fund size, puts it at 87/100.

Cost: At 0.72%, the expense ratio is meaningfully cheaper — about 16% below the Mid Cap category average of 0.86% (based on 147 comparable funds). Lower costs compound in your favour over long holding periods.

Risk-adjusted performance: Over the trailing 1-year period, the fund shows a modest Sharpe ratio of 0.49 — returns have only marginally compensated for the risk taken. Separately, annualised volatility of 16.28% is fairly typical for actively managed equity funds.

Who should invest: This fund is best suited to investors with a 5+ year horizon comfortable with meaningfully higher volatility than large cap funds. Given the Very High risk rating, this fund is not suited to short-term goals or investors who may need to exit within 2-3 years.